Bigio I. J. Bown S. G. Briggs G. Kelley C. Lakhani S. Pickard D. Ripley P. M. Rose I. G. Saunders C. Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. 5 2 4 2000 221 228 J Biomed Opt 10938787 10.1117/1.429990
Brown N. S. Jones A. Fujiyama C. Harris A. L. Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. 60 22 15 11 2000 6298 6302 Cancer Res 11103787
Carragher N. O. Fincham V. J. Riley D. Frame M. C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. 276 6 7 11 2000 4270 4275 J Biol Chem 11069922 10.1074/jbc.M008972200
Greco O. Folkes L. K. Wardman P. Tozer G. M. Dachs G. U. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. 7 11 11 2000 1414 1420 Cancer Gene Ther 11129283 10.1038/sj.cgt.7700258
Grob J. J. Dreno B. de la Salmonière P. Delaunay M. Cupissol D. Guillot B. Souteyrand P. Sassolas B. Cesarini J. P. Lionnet S. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma. 351 9120 27 6 1998 1905 1910 Lancet 9654256 10.1016/s0140-6736(97)12445-x
Malik K. Brown K. W. Epigenetic gene deregulation in cancer. 83 12 12 2000 1583 1588 Br J Cancer PMC2363469 11104550 10.1054/bjoc.2000.1549
Malik K. Salpekar A. Hancock A. Moorwood K. Jackson S. Charles A. Brown K. W. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. 60 9 1 5 2000 2356 2360 Cancer Res 10811108
Marriott J. B. Muller G. Dalgleish A. G. Thalidomide as an emerging immunotherapeutic agent. 20 12 12 1999 538 540 Immunol Today 10562702 10.1016/s0167-5699(99)01531-5
Maxwell P. H. Dachs G. U. Gleadle J. M. Nicholls L. G. Harris A. L. Stratford I. J. Hankinson O. Pugh C. W. Ratcliffe P. J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. 94 15 22 7 1997 8104 8109 Proc Natl Acad Sci U S A PMC21564 9223322 10.1073/pnas.94.15.8104
Pignon J. P. Bourhis J. Domenge C. Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. 355 9208 18 3 2000 949 955 Lancet 10768432
Plumb J. A. Strathdee G. Sludden J. Kaye S. B. Brown R. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. 60 21 1 11 2000 6039 6044 Cancer Res 11085525
Strathdee G. MacKean M. J. Illand M. Brown R. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. 18 14 8 4 1999 2335 2341 Oncogene 10327053 10.1038/sj.onc.1202540
Sturla L. M. Westwood G. Selby P. J. Lewis I. J. Burchill S. A. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. 60 21 1 11 2000 6160 6170 Cancer Res 11085540